Sandu Pharmaceuticals Limited has intimated the Bombay Stock Exchange about an upcoming Board of Directors meeting scheduled for Saturday, July 11, 2026, at 4:00 PM at the Corporate Office located at Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071.
The Board meeting agenda includes four key items:
1. To formally record the demise of Shri Umesh B. Sandu (DIN: 01132141), the Managing Director of the Company, who passed away on June 19, 2026. The Board will also record its appreciation for his invaluable contributions to the Company.
2. To consider and approve the appointment of a new Managing Director following the demise of Late Shri Umesh B. Sandu. This appointment is subject to approval by the company's shareholders and any other required statutory and regulatory approvals.
3. To consider and approve the reconstitution of the various Committees of the Board.
4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive). This appointment is also subject to shareholder approval and any other necessary statutory and regulatory approvals.
Additionally, in compliance with the Company's Code of Conduct for prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the company's securities has been closed for all Directors, Officers, and designated employees. The closure period began at the opening of trading hours on Wednesday, July 1, 2026, and will remain closed until 48 hours after the public announcement of the financial results for the quarter ended June 30, 2026.